Renhe Pharmacy Co., Ltd.
Σύμβολο: 000650.SZ
SHZ
6.57
CNYΤιμή αγοράς σήμερα
13.8854
Λόγος P/E
3.1936
Δείκτης PEG
9.20B
MRK Cap
- 0.03%
DIV Απόδοση
Renhe Pharmacy Co., Ltd. (000650-SZ) Οικονομικές καταστάσεις
Ισολογισμός
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 12028.24 | 3242.3 | 2676 | 2168.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 5637.48 | 416.9 | 315.6 | 460.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 3217.73 | 582.5 | 647.3 | 501.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 1806.76 | 457.7 | 601.4 | 451.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 1566.18 | 298.3 | 131 | 711.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 18618.91 | 4580.9 | 4055.7 | 3833.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4986.1 | 1240.7 | 1111.6 | 744 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 2312.95 | 578.2 | 606.1 | 102.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 2462.49 | 602.2 | 650.6 | 664.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 4775.44 | 1180.4 | 1256.8 | 766.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | -3458.37 | 119.5 | 77.1 | 439.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 71.29 | 17.7 | 6.6 | 5.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 5902.29 | 492.4 | 400.2 | 516.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 12276.76 | 3050.8 | 2852.2 | 2471.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 30895.67 | 7631.6 | 6907.9 | 6305.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 1296.75 | 199.6 | 176.1 | 147.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 16.88 | 6.7 | 2.8 | 60.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 863.94 | 279.9 | 273.8 | 126.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 23.17 | 5.8 | 3.6 | 2.7 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 154.4 | 38.8 | 8.3 | 9.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 2.08 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 1205.38 | 603.6 | 51.5 | 42.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 180.38 | 45.3 | 12.3 | 9.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 23.17 | 5.8 | 3.6 | 2.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 4461.31 | 1209.9 | 981 | 694.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 5599.75 | 1399.9 | 1399.9 | 1399.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 13087.09 | 3142 | 2742.7 | 2412.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4012.01 | 415.3 | 390.6 | 307.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 783.55 | 783.6 | 754.1 | 953.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 23482.4 | 5740.8 | 5287.2 | 5072.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 30895.67 | 7631.6 | 6907.9 | 6305.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 2951.95 | 681 | 639.7 | 537.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 26434.35 | 6421.8 | 5926.9 | 5610.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 30895.67 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 2179.11 | 536.4 | 392.7 | 900 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 40.06 | 12.5 | 6.5 | 60.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | -6350.71 | -2813 | -2354 | -1647.8 |
Κατάσταση ταμειακών ροών
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 658.36 | 711.6 | 799.9 | 657.7 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 118.85 | 117.2 | 86.6 | 83.9 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -254.17 | -10.8 | -0.8 | 1.1 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 17.32 | 17.3 | 10.4 | -1.1 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 238.73 | 410.2 | -86.3 | 194.5 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 127.1 | 127.1 | -62.5 | 54.2 | |||||||||||||||||||||||||
cash-flows.row.inventory | 111.63 | 111.6 | -124.4 | 69.8 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 182.3 | 101.3 | 68.9 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -10.8 | -0.8 | 1.7 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | -80.5 | 24.6 | -32.1 | -64.9 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 698.58 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -197.29 | -221.1 | -499.8 | -218.2 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 1.26 | 15.8 | -704.6 | 188.8 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -6122.14 | -8033 | -10846.8 | -11925 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 6052 | 7662.9 | 12347.9 | 10753.2 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -1.21 | 0.3 | 22.6 | 1.1 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -267.38 | -575.2 | 319.3 | -1200.1 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -5.5 | -60 | -60 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 139.7 | -0.7 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -199.6 | -59.3 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | -280.16 | -140.2 | -283.2 | -169.6 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | -368.02 | -84.4 | -59.1 | 907.2 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -368.2 | -230.1 | -462.2 | 617.6 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 817.23 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 552.16 | 464.7 | 634.8 | 288.6 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 6370.97 | 2825.2 | 2360.4 | 1707.9 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 5818.81 | 2360.4 | 1725.6 | 1419.2 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 698.58 | 1270 | 777.7 | 871.1 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -197.29 | -221.1 | -499.8 | -218.2 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 501.3 | 1048.9 | 277.9 | 652.9 |
Σειρά κατάστασης λογαριασμού αποτελεσμάτων
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 5126.13 | 5153.2 | 4935.8 | 4106.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 3179.36 | 3266.3 | 3061.4 | 2456.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 1946.77 | 1886.9 | 1874.3 | 1650 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 40.41 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 86.14 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 552.45 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 275.74 | 269.6 | 224.8 | 194.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 928.5 | 947.3 | 929.9 | 864.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 4107.86 | 4213.6 | 3991.4 | 3320.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 23.21 | 24.2 | 56.7 | 10.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0.38 | 0.4 | 1 | 1.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 552.45 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.93 | 0.3 | -2.5 | -12.9 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 275.74 | 269.6 | 224.8 | 194.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.93 | 0.3 | -2.5 | -12.9 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0.38 | 0.4 | 1 | 1.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 51.47 | 173.6 | 79.3 | 77.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1112.25 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 1060.78 | 953.3 | 1036.9 | 860.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 1061.71 | 953.5 | 1034.4 | 847.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 264.64 | 242 | 234.5 | 190 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 658.36 | 574.4 | 665 | 580.2 |
Συχνές ερωτήσεις
Ποιο είναι το Renhe Pharmacy Co., Ltd. (000650.SZ) το σύνολο του ενεργητικού?
Renhe Pharmacy Co., Ltd. (000650.SZ) το συνολικό ενεργητικό είναι 7631643912.000.
Ποια είναι τα ετήσια έσοδα της επιχείρησης?
Τα ετήσια έσοδα είναι 2462891768.000.
Ποιο είναι το περιθώριο κέρδους της επιχείρησης?
Το περιθώριο κέρδους της επιχείρησης είναι 0.380.
Ποια είναι η ελεύθερη ταμειακή ροή της επιχείρησης?
Η ελεύθερη ταμειακή ροή είναι 0.358.
Ποιο είναι το καθαρό περιθώριο κέρδους της επιχείρησης?
Το καθαρό περιθώριο κέρδους είναι 0.128.
Ποια είναι τα συνολικά έσοδα της επιχείρησης?
Τα συνολικά έσοδα είναι 0.207.
Ποια είναι η Renhe Pharmacy Co., Ltd. (000650.SZ) καθαρό κέρδος (καθαρό εισόδημα)?
Το καθαρό κέρδος (καθαρό εισόδημα) είναι 574441773.000.
Ποιο είναι το συνολικό χρέος της επιχείρησης?
Το συνολικό χρέος είναι 12516083.000.
Ποιος είναι ο αριθμός των λειτουργικών εξόδων?
Τα λειτουργικά έξοδα είναι 947338541.000.
Ποιος είναι ο αριθμός των ταμειακών διαθεσίμων της εταιρείας?
Τα ταμειακά διαθέσιμα της επιχείρησης είναι 1227293992.000.